Biblio
Injectable photocurable Janus hydrogel delivering hiPSC cardiomyocyte-derived exosome for post-heart surgery adhesion reduction. Sci Adv. 2023;9(31):eadh1753.
Low incidence of relapse with moderate conditioning regimen of fludarabine, busulfan and melphalan for patients with myeloid malignancies: a single-center analysis of 100 patients. Transplant Cell Ther. 2023.
. mutation yields supercompetitive B cells primed for malignant transformation. Science. 2023;379(6629):eabj7412.
Novel terpestacin derivatives with l-amino acid residue as anticancer agents against U87MG-derived glioblastoma stem cells. Bioorg Chem. 2023;132:106392.
. Orchestrating Chemical and Physical Cross-Linking in Protein Hydrogels to Regulate Embryonic Stem Cell Growth. ACS Macro Lett. 2023:269-273.
. . Decitabine in combination with idarubicin within a modified busulfan/cyclophosphamide conditioning regimen for patients with advanced myelodysplastic syndrome: A prospective multicenter clinical cohort study. Chin Med J (Engl). 2024.
Post-transplant cyclophosphamide at 80 mg/kg with low dose post-engraftment anti-thymocyte globulin in haploidentical transplantation with myeloablative conditioning. Bone Marrow Transplant. 2024.
. Preschool children's asthma medication: parental knowledge, attitudes, practices, and adherence. Front Pharmacol. 2024;15:1292308.
. STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells. Cell Death Dis. 2024;15(4):265.